냉각 통증 치료(Cold Pain Therapy) 시장 : 2027년까지 의 세계 예측

출판 : MarketsandMarkets(마켓츠앤마켓츠)출판년월 : 2022년06월

냉각 통증 치료(Cold Pain Therapy) 시장 : 제품[OTC(젤, 크림, 패치, 랩, 패드), 처방(전동, 비전동)], 용도(근골격, 수술 후, 스포츠 상해), 유통 채널(병원, 소매, 전자 약국) – 2027년까지 의 세계 예측

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

페이지수 240
도표수 285
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost.
세계 냉각 통증 치료 시장은 예측 기간 동안 5.1%의 CAGR로 2022년 18억 달러에서 2027년 24억 달러에 이를 것으로 예상됩니다. 이 시장의 성장은 주로 관절염 발병률 증가와 저렴한 비용으로 감기 통증 제품의 가용성에 의해 주도됩니다.

“The OTC products segment accounted for the highest growth rate in thecold pain therapymarket, by product, during the forecast period.”
The cold pain therapy market is segmented into OTC products and prescription productsbased on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attributed to the easy accessibility of OTC products in retail and online pharmacies.
“E-pharmacies segment accounted for the highest CAGR.”
Based on the distribution channel, the cold pain therapy market has been segmented into hospital pharmacies, retail pharmacies, and e-pharmacies. In 2021, the e-pharmaciessegment accounted for the highest growth rate. This can be attributed to the easy accessibility of medications coupled with added discounts.
“Asia Pacific: The fastest-growing regioncold pain therapymarket.”
The global cold pain therapy market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as increasing geriatric population coupled with rising prevalence of arthritis and other musculoskeletal disorders.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

• Beiersdorf AG (Germany)
• DJO Global, Inc. (US)
• Hisamitsu Pharmaceutical Co., Inc. (Japan)
• Össur (Iceland)
• Johnson & Johnson (US)
• Pfizer (US)
• Sanofi (France)
• Rohto Pharmaceutical (Japan)
• 3M (US)
• Cardinal Health Inc. (US)
• Bird & Cronin (US)
• Compass Health Brands (US)
• Breg, Inc. (US)
• Medline Industries (US)
• Performance Health (US)
• Romsons Group of Industries (India
• Unexo Life Sciences (India)
• Polar Products (US)
• Rapid Aid (Canada)
• Mueller Sports Medicine (US)
• Pic Solution (US)
• Bruder Healthcare Company (US)
• Brownmed Inc. (US)
• Medichill (Australia)
• ThermoTek, Inc. (US)


Research Coverage:
This report provides a detailed picture of the global cold pain therapymarket. It aims at estimating the size and future growth potential of the market across different segments, such as product,application, distribution channel,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cold pain therapy market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 34)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKETS COVERED
1.3.1 COLD PAIN THERAPY MARKET
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 39)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 COLD PAIN THERAPY MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (COLD PAIN THERAPY MARKET)
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 COLD PAIN THERAPY MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
2.8.1 RISK ASSESSMENT: COLD PAIN THERAPY MARKET
2.9 GROWTH RATE ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. – 51)
FIGURE 8 COLD PAIN THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 COLD PAIN THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
FIGURE 11 COLD PAIN THERAPY MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. – 54)
4.1 COLD PAIN THERAPY MARKET OVERVIEW
FIGURE 12 GROWING PREVALENCE OF MUSCULOSKELETAL CONDITIONS AND INCREASING PARTICIPATION IN SPORTS TO DRIVE MARKET GROWTH
4.2 COLD PAIN THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027
FIGURE 13 OTC PRODUCTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2027
4.3 COLD PAIN THERAPY MARKET SHARE, BY APPLICATION, 2022 VS. 2027
FIGURE 14 MUSCULOSKELETAL DISORDERS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 COLD PAIN THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027
FIGURE 15 RETAIL PHARMACIES SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2027
4.5 COLD PAIN THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE COLD PAIN THERAPY MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 57)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 COLD PAIN THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of sports injuries and rising emphasis on exercise and gym activities
5.2.1.2 Growing number of hip and knee surgeries across the globe
5.2.1.3 Rising geriatric population and subsequent growth in the prevalence of bone diseases and trauma injuries
5.2.1.4 Growing need for safer pain management modalities as opposed to oral drug therapy
5.2.1.5 Clinical evidence in favor of menthol-based topical analgesics
5.2.2 RESTRAINTS
5.2.2.1 Wide use of low-priced analgesic pills for immediate pain relief
5.2.2.2 Lack of substantial clinical evidence and reimbursement in favor of cold pain therapy
5.2.2.3 Health hazards and discomfort associated with cold pain therapy products
5.2.3 OPPORTUNITIES
5.2.3.1 Growing adoption of analgesic patches
5.2.3.2 Growing use of cold pain therapy among middle-aged women
5.2.3.3 Increasing regulatory barriers for oral pain medications
5.2.4 CHALLENGES
5.2.4.1 Availability of alternative non-drug/device pain management therapies
5.2.5 IMPACT OF COVID-19 ON THE COLD PAIN THERAPY MARKET
5.3 PRICING ANALYSIS
TABLE 1 AVERAGE SELLING PRICE OF COLD PAIN THERAPY PRODUCTS (2022)
5.4 PATENT ANALYSIS
FIGURE 18 PATENT ANALYSIS FOR MOTORIZED COLD PAIN THERAPY DEVICES
TABLE 2 LIST OF KEY PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS OF THE COLD PAIN THERAPY MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 20 COLD PAIN THERAPY MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM/MARKET MAP
FIGURE 21 COLD PAIN THERAPY MARKET: ECOSYSTEM/MARKET MAP
TABLE 3 COLD PAIN THERAPY MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 COLD PAIN THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 DEGREE OF COMPETITION
5.9 REGULATORY LANDSCAPE
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.1 NORTH AMERICA
5.9.1.1 US
5.9.1.2 Canada
5.9.2 EUROPE
5.9.3 ASIA PACIFIC
5.9.3.1 Japan
5.9.3.2 India
5.9.4 LATIN AMERICA
5.9.4.1 Brazil
5.9.4.2 Mexico
5.9.5 MIDDLE EAST
5.9.6 AFRICA
5.10 TRADE ANALYSIS
5.10.1 TRADE ANALYSIS FOR COLD PAIN THERAPY PRODUCTS
TABLE 10 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR SPORTS AND OUTDOOR GAMES, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 11 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR SPORTS AND OUTDOOR GAMES, BY COUNTRY, 2017–2021 (USD MILLION)
5.11 TECHNOLOGY ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 12 COLD PAIN THERAPY MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SOURCES ARE SHIFTING TOWARD SAFER PAIN MANAGEMENT DUE TO THE COVID-19 PANDEMIC
FIGURE 22 REVENUE SHIFT IN THE COLD PAIN THERAPY MARKET
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF COLD PAIN THERAPY PRODUCTS
TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF COLD PAIN THERAPY PRODUCTS
5.14.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR COLD PAIN THERAPY PRODUCTS
TABLE 14 KEY BUYING CRITERIA FOR COLD PAIN THERAPY PRODUCTS
5.15 CASE STUDIES
5.15.1 CASE STUDY 1

6 COLD PAIN THERAPY MARKET, BY PRODUCT (Page No. – 85)
6.1 INTRODUCTION
TABLE 15 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 OTC PRODUCTS
TABLE 16 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 18 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
TABLE 19 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1 OTC PHARMACEUTICALS
TABLE 20 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 22 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
TABLE 23 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.1 Gels, ointments, and creams
6.2.1.1.1 Gels, ointments, and creams offer effective orthopedic pain management
TABLE 24 KEY GELS, OINTMENTS, AND CREAMS AVAILABLE IN THE MARKET
TABLE 25 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 26 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 27 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.2.1.2 Sprays and foams
6.2.1.2.1 Procedural benefits offered by sprays and foams to increase their adoption among sportspersons
TABLE 28 KEY SPRAYS AND FOAMS AVAILABLE IN THE MARKET
TABLE 29 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY REGION, 2020–2027 (USD MILLION)
TABLE 30 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 31 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.2.1.3 Patches
6.2.1.3.1 Ability to deliver consistent dosage of drugs over topical creams resulting in the greater consumption of cold pain patches
TABLE 32 KEY PATCHES AVAILABLE IN THE MARKET
TABLE 33 COLD PAIN THERAPY MARKET FOR PATCHES, BY REGION, 2020–2027 (USD MILLION)
TABLE 34 COLD PAIN THERAPY MARKET FOR PATCHES, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 35 COLD PAIN THERAPY MARKET FOR PATCHES, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.2.1.4 Roll-ons
6.2.1.4.1 Inconsistent drug delivery and the need for repetitive use on skin are expected to hamper the adoption of roll-ons
TABLE 36 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 37 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 38 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.2.2 OTC MEDICAL DEVICES
TABLE 39 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 41 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
TABLE 42 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2.1 Cold packs
6.2.2.1.1 Cold packs are among the widely used cold pain therapy medical devices
TABLE 43 KEY COLD PACKS AVAILABLE IN THE MARKET
TABLE 44 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY REGION, 2020–2027 (USD MILLION)
TABLE 45 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 46 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.2.2.2 Cooling towels, compresses, wraps, and pads
6.2.2.2.1 Growing availability of wraps and cooling pads to aid the growth of this market segment
TABLE 47 KEY COOLING TOWELS, COMPRESSES, WRAPS, AND PADS AVAILABLE IN THE MARKET
TABLE 48 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY REGION, 2020–2027 (USD MILLION)
TABLE 49 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 50 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.3 PRESCRIPTION PRODUCTS
TABLE 51 KEY PRESCRIPTION PRODUCTS AVAILABLE IN THE MARKET
TABLE 52 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 54 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
TABLE 55 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.1 MOTORIZED DEVICES
6.3.1.1 Preference for motorized devices is increasing among patients
TABLE 56 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY REGION, 2020–2027 (USD MILLION)
TABLE 57 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 58 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
6.3.2 NON-MOTORIZED DEVICES
6.3.2.1 Non-motorized devices cost lower as compared to motorized devices
TABLE 59 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 61 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)

7 COLD PAIN THERAPY MARKET, BY APPLICATION (Page No. – 112)
7.1 INTRODUCTION
TABLE 62 COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 MUSCULOSKELETAL DISORDERS
7.2.1 INCREASING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
TABLE 63 COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2020–2027 (USD MILLION)
7.3 POST-OPERATIVE THERAPY
7.3.1 INCREASING NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES TO DRIVE SEGMENT GROWTH
TABLE 64 COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2020–2027 (USD MILLION)
7.4 POST-TRAUMA THERAPY
7.4.1 INCREASING INCIDENCE OF TRAUMA INJURIES TO PROPEL SEGMENT GROWTH
TABLE 65 COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2020–2027 (USD MILLION)
7.5 SPORTS INJURIES
7.5.1 INCREASING NUMBER OF SPORTS INJURIES TO DRIVE SEGMENT GROWTH
TABLE 66 COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY REGION, 2020–2027 (USD MILLION)

8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL (Page No. – 118)
8.1 INTRODUCTION
TABLE 67 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
8.2 RETAIL PHARMACIES
8.2.1 RETAIL PHARMACIES FORM THE LARGEST DISTRIBUTION CHANNEL FOR COLD PAIN THERAPY PRODUCTS
TABLE 68 COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION, 2020–2027 (USD MILLION)
8.3 HOSPITAL PHARMACIES
8.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
TABLE 69 COLD PAIN THERAPY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020–2027 (USD MILLION)
8.4 E-PHARMACIES
8.4.1 E-PHARMACIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
TABLE 70 COLD PAIN THERAPY MARKET FOR E-PHARMACIES, BY REGION, 2020–2027 (USD MILLION)

9 COLD PAIN THERAPY MARKET, BY REGION (Page No. – 123)
9.1 INTRODUCTION
TABLE 71 COLD PAIN THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: COLD PAIN THERAPY MARKET SNAPSHOT
TABLE 72 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 73 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Strong presence of key companies has driven market growth in the US
TABLE 76 US: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 77 US: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 US: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 US: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 US: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 US: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 82 US: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Market growth is driven by the rising number of hip and knee replacement surgeries
TABLE 83 CANADA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 84 CANADA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 CANADA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 CANADA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 CANADA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 CANADA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 90 EUROPE: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 93 EUROPE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing healthcare expenditure to drive market growth in Germany
TABLE 94 GERMANY: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 95 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 GERMANY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 GERMANY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 GERMANY: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 GERMANY: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Market growth in the UK is mainly driven by the increasing prevalence of musculoskeletal conditions
TABLE 101 UK: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 102 UK: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 UK: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 UK: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 UK: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 UK: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 107 UK: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing target patient population to drive market growth in France
TABLE 108 FRANCE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 109 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 FRANCE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 FRANCE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 FRANCE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 FRANCE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growing public awareness about the preventive care of musculoskeletal disorders to drive market growth
TABLE 115 ITALY: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 ITALY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 ITALY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 ITALY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 ITALY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ITALY: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 121 ITALY: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing prevalence of target diseases to drive market growth
TABLE 122 SPAIN: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 123 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 SPAIN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 SPAIN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 SPAIN: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 128 SPAIN: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 129 NUMBER OF SURGERIES CONDUCTED IN ROE COUNTRIES
TABLE 130 ROE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 131 ROE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 ROE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 ROE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 ROE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 ROE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 136 ROE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 26 APAC: COLD PAIN THERAPY MARKET SNAPSHOT
TABLE 137 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 138 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 139 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 140 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Increasing geriatric population to drive market growth in Japan
TABLE 141 JAPAN: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 JAPAN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 JAPAN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 JAPAN: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 147 JAPAN: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Expansion in the target patient population to drive market growth
TABLE 148 CHINA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 149 CHINA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 CHINA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 CHINA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 CHINA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 CHINA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 154 CHINA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing number of arthritis cases to drive market growth
TABLE 155 INDIA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 156 INDIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 INDIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 INDIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 INDIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 INDIA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 161 INDIA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Rising prevalence of target diseases to drive market growth
TABLE 162 AUSTRALIA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 163 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 AUSTRALIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 AUSTRALIA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 168 AUSTRALIA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives are expected to positively impact market growth
TABLE 169 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 170 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 175 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 176 ROAPAC: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 177 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 ROAPAC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 ROAPAC: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 182 ROAPAC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 183 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 184 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 185 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 186 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Growing obese population will drive market growth in Brazil
TABLE 187 BRAZIL: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 BRAZIL: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 BRAZIL: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 193 BRAZIL: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 194 MEXICO: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 195 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 MEXICO: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 MEXICO: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 MEXICO: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 200 MEXICO: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 201 ROLATAM: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 202 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 ROLATAM: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 ROLATAM: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 207 ROLATAM: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 208 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. – 187)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE COLD PAIN THERAPY MARKET
TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COLD PAIN THERAPY PRODUCT MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE COLD PAIN THERAPY MARKET
10.4 MARKET SHARE ANALYSIS
10.4.1 COLD PAIN THERAPY MARKET
FIGURE 28 COLD PAIN THERAPY MARKET SHARE, BY KEY PLAYER (2021)
TABLE 212 COLD PAIN THERAPY MARKET: DEGREE OF COMPETITION
10.4.2 EUROPE: COLD PAIN THERAPY MARKET SHARE OF PLAYERS
FIGURE 29 EUROPE: COLD PAIN THERAPY MARKET SHARE OF TOP 3 PLAYERS (2021)
10.4.3 EUROPE: LIST OF KEY PLAYERS (2021)
10.5 COMPANY EVALUATION MATRIX
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 30 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 31 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
FIGURE 32 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE COLD PAIN THERAPY MARKET
TABLE 213 COLD PAIN THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 214 PRODUCT FOOTPRINT OF KEY PLAYERS
TABLE 215 REGIONAL FOOTPRINT OF KEY PLAYERS
TABLE 216 COLD PAIN THERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 217 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
10.8.2 DEALS
TABLE 218 KEY DEALS

11 COMPANY PROFILES (Page No. – 199)
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 BEIERSDORF AG
TABLE 219 BEIERSDORF AG: BUSINESS OVERVIEW
FIGURE 33 BEIERSDORF AG: COMPANY SNAPSHOT (2021)
11.1.2 DJO GLOBAL, INC.
TABLE 220 DJO GLOBAL, INC.: BUSINESS OVERVIEW
FIGURE 34 DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020)
11.1.3 HISAMITSU PHARMACEUTICAL CO., INC.
TABLE 221 HISAMITSU PHARMACEUTICAL CO., INC.: BUSINESS OVERVIEW
FIGURE 35 HISAMITSU PHARMACEUTICAL CO., INC.: COMPANY SNAPSHOT (2021)
11.1.4 ÖSSUR
TABLE 222 ÖSSUR: BUSINESS OVERVIEW
FIGURE 36 ÖSSUR: COMPANY SNAPSHOT (2021)
11.1.5 JOHNSON & JOHNSON
TABLE 223 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
11.1.6 PFIZER
TABLE 224 PFIZER: BUSINESS OVERVIEW
FIGURE 38 PFIZER: COMPANY SNAPSHOT (2021)
11.1.7 SANOFI
TABLE 225 SANOFI: BUSINESS OVERVIEW
FIGURE 39 SANOFI: COMPANY SNAPSHOT (2021)
11.1.8 ROHTO PHARMACEUTICAL
TABLE 226 ROHTO PHARMACEUTICAL: BUSINESS OVERVIEW
FIGURE 40 ROHTO PHARMACEUTICAL: COMPANY SNAPSHOT (2021)
11.1.9 3M
TABLE 227 3M: BUSINESS OVERVIEW
FIGURE 41 3M: COMPANY SNAPSHOT (2021)
11.1.10 CARDINAL HEALTH, INC.
TABLE 228 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 BREG, INC.
TABLE 229 BREG, INC.: COMPANY OVERVIEW
11.2.2 MEDLINE INDUSTRIES, INC.
TABLE 230 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
11.2.3 PERFORMANCE HEALTH
TABLE 231 PERFORMANCE HEALTH: COMPANY OVERVIEW
11.2.4 ROMSONS GROUP OF INDUSTRIES
TABLE 232 ROMSONS GROUP OF INDUSTRIES: COMPANY OVERVIEW
11.2.5 UNEXO LIFE SCIENCES PVT. LTD.
TABLE 233 UNEXO LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
11.2.6 BIRD & CRONIN LLC
TABLE 234 BIRD & CRONIN LLC: COMPANY OVERVIEW
11.2.7 POLAR PRODUCTS INC.
TABLE 235 POLAR PRODUCTS INC.: COMPANY OVERVIEW
11.2.8 RAPID AID CORP.
TABLE 236 RAPID AID CORP.: COMPANY OVERVIEW
11.2.9 MUELLER SPORTS MEDICINE, INC.
TABLE 237 MUELLER SPORTS MEDICINE, INC.: COMPANY OVERVIEW
11.2.10 PIC SOLUTION
TABLE 238 PIC SOLUTION: COMPANY OVERVIEW
11.2.11 BRUDER HEALTHCARE COMPANY
TABLE 239 BRUDER HEALTHCARE COMPANY: COMPANY OVERVIEW
11.2.12 BROWNMED INC.
TABLE 240 BROWNMED INC.: COMPANY OVERVIEW
11.2.13 MEDICHILL
TABLE 241 MEDICHILL: COMPANY OVERVIEW
11.2.14 COMPASS HEALTH BRANDS
TABLE 242 COMPASS HEALTH BRANDS: COMPANY OVERVIEW
11.2.15 THERMOTEK, INC.
TABLE 243 THERMOTEK, INC.: COMPANY OVERVIEW

12 APPENDIX (Page No. – 243)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com